Chemotherapy for multiple myeloma

Last medical review:

Chemotherapy uses drugs to destroy cancer cells. These drugs target rapidly dividing cells throughout the whole body. This means that chemotherapy kills cancer cells but it can also damage healthy cells.

With most types of chemotherapy, the drugs travel through the blood to reach and destroy cancer cells all over the body, including cells that may have broken away from the primary tumour. This is described as systemic therapy.

Most people with multiple myeloma have chemotherapy. If you have chemotherapy, your healthcare team will use what they know about the cancer and about your health to plan the drugs, doses and schedules.

Chemotherapy may be used along with other cancer treatments. You may have chemotherapy to:

  • destroy cancer cells in the body
  • lower the number of cancer cells in the body before a stem cell transplant (called induction therapy)
  • lower the number of cancer cells in the body when you can't have a stem cell transplant
  • destroy cells in the bone marrow as part of stem cell transplant conditioning
  • treat multiple myeloma that has come back after it was treated (called relapsed multiple myeloma) or is no longer responding to treatment (called refractory multiple myeloma)

Chemotherapy drugs used for multiple myeloma

Chemotherapy drugs are usually combined with targeted therapy drugs or supportive therapy drugs or both.

The most common chemotherapy drugs used to treat multiple myeloma are:

  • melphalan
  • cyclophosphamide

The most common combinations of chemotherapy drugs used to treat multiple myeloma are:

  • CyBorD – cyclophosphamide, bortezomib (Velcade) and dexamethasone
  • Dara-CyBorD – daratumumab (Darzalex), cyclophosphamide, bortezomib and dexamethasone
  • VTd-PACE – bortezomib, thalidomide (Thalomid), low-dose dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide
  • KCd – carfilzomib (Kyprolis), cyclophosphamide and low-dose dexamethasone
  • PCP – pomalidomide (Pomalyst), cyclophosphamide and prednisone

Side effects of chemotherapy

Side effects of chemotherapy will depend mainly on the drug, the dose, how it's given and your overall health. Tell your healthcare team if you have side effects that you think are from chemotherapy. The sooner you tell them of any problems, the sooner they can suggest ways to help you deal with them.

Common side effects of chemotherapy drugs for multiple myeloma include:

Find out more about chemotherapy

Find out more about chemotherapy and side effects of chemotherapy. To make the decisions that are right for you, ask your healthcare team questions about chemotherapy.

Details on specific drugs change regularly. Find out more about sources of drug information and where to get details on specific drugs.

Expert review and references

  • Guido Lancman, MD, MSc
  • Guideline Resource Unit (GURU). Multiple Myeloma: Management of Relapsed/Refractory Disease. Edmonton: Alberta Health Services; 2023: Clinical Practice Guideline LYHE-015 Version: 1. https://www.albertahealthservices.ca/info/cancerguidelines.aspx.
  • Guideline Resource Unit (GURU). Multiple Myeloma: Transplant Eligible. Edmonton: Alberta Health Services; 2023: Clinical Practice Guideline LYHE–013 Version: 1. https://www.albertahealthservices.ca/info/cancerguidelines.aspx.
  • Guideline Resource Unit (GURU). Multiple Myeloma: Transplant Ineligible. Edmonton: Alberta Health Services; 2023: Clinical Practice Guideline LYHE–014 Version: 1. https://www.albertahealthservices.ca/info/cancerguidelines.aspx.
  • Mikhael J, Ismaila N, Cheung MC, et al. Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline. Journal of Clinical Oncology. 2019: 37(14):1228–1263.
  • Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk-stratification and management. American Journal of Hematology. 2022: 97(8):1086–1107.
  • Rajkumar V, Kumar S. Plasma Cell Neoplasms. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, [chapter 74], https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society